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1. Introduction 
Daunomycin is an antibiotic of the anthracycline 
group isolated from cultures of Streptomyces peucetius 
[ 1,2] . This antibiotic consists of a pigmented aglycone 
(daunomycinone) bound by a glycosidic linkage to an 
amino sugar (daunosamine, fig. 1)[3,4]. The biologi- 
cal activity of daunomycin is dependent on its ability 
to interact with primer DNA [5]. The inhibition of 
DNA-polymerase activity in RNA tumor viruses by 
daunomycin has been recently studied [6,7]. Whereas, 
Miller et al. [6] got 50% inhibition of the DNA-poly- 
merase reaction at 2 pg/ml of daunomycin, Hirschman 
[7] reported only 30% inhibition at 100 pg/ml. The 
present communication describes the effect of dauno- 
mycin and its structural analogues on the DNA-poly- 
merase activity of Friend Leukemia virions (FLV), 
Murine Sarcoma virus-Moloney (MSV-M) and Rous 
Sarcoma virus (RSV). These studies were carried out 
using various templates,e.g. poly (dA-dT), poly 
(dI.dC) and poly rA.(dT)i 2. The results show that 
the inhibitory action of daunomycin and its deriva- 
tives is a template specific one. The substitutions in 
the amino sugar moiety lead to an inactivation of the 
daunomycin molecule. 
*Correspondance should be sent to: Professor P. Chandra, 
lnstitut fiir Therapeutische Biochemie der Universitlt, 
D-6 Frankfurt/M., Ludwig-Rehn Str. 14, W. Germany. 
**Permanent address: Istituto Nazionale per lo Studio e la 
cura dei Tumori, Milan, Italy. 
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2. Materials and methods 
3 H-labeled deoxynucleoside triphosphates were 
obtained from NEN-Chemicals GmbH, Germany. 
Unlabeled deoxynucleoside triphosphates were pur- 
chased from Nutritional Biochemical Corp., Ohio, 
USA. Poly (dA - dT) and poly rA were supplied by 
Miles Chemical Laboratories, Elkhart, Indiana, USA. 
Poly (dI.dC) and poly rA.(dT), 2 were provided by 
Dr. G. Weimann of Boehringer Mannheim, Tutzing. 
MSV-M, kindly supplied by Dr. J.B. Moloney 
(NCI, Bethesda, Md.) was passed by intramuscular 
injection intosuckling Swiss mice, and extracted 
from the tumor tissue. FLV was isolated from in- 
fected spleens (AKR mice) and purified by sucrose- 
density gradient centrifugation. RSV was isolated 
from tumors grown on chickens and purified by 
sucrose-density gradient centrifugation. The viral 
extracts used to assay for DNA-polymerase activity 
were stored at -70” before use. 
DNA-polymerase assay: DNA-polymerase activi- 
ty was assayed essentially by the method of Ross 
et al. [8]. The reaction mixture, regardless of tem- 
plate, was similar to that of Ross et al. [8] , except 
that we used 0.04 M Tris and the end concentration 
of Nonidet P-40 (Shell Chemie, Hamburg) was 0.2%. 
The reaction mixture contained 0.25 c(g of the tem- 
plate used. The reaction mixture (0.25 ml) contain- 
ing viricn (28 pg of protein) was incubated at 37” 
for 90 min. Acid precipitable material was counted 
North-Holland hblishing Company - Amsterdam 
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CHEMICAL STRUCTURES OF OAUNOMYCIN DERIVATIVES 
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Fig. 1. Chemical structures of daunomycin derivatives. 
on “Millipore” filters (HAWP 02500) in a liquid scin- 
tillation counter. Protein was estimated by the meth- 
od of Lowry et al. [9]. 
3. Results and discussion 
The inhibitory effect of different daunomycin 
derivatives (fig. 1) on the viral oncogenesis by FLV 
and RSV is shown in table 1. FLV suspensions were 
prepared by filtering the homogenates from infected 
spleens (AKR mice) through Seitz EK-filters (Seitz 
Company, Bad Kreuznach, Germany). This suspen- 
sioh was diluted 1: 20 with Hank’s solution. The 
diluted suspension was incubated with daunomycin 
or its derivatives (50 pg/ ml) for 1 hr at 37”. The 
control suspensions were incubated under similar 
conditions, without the antibiotic. 0.1 ml of this 
suspension (IDgo) was injected intraperitoneally. Each 
experimental group contained 6 animals. As follows 
from table 1 5 of the 6 control animals died after 13 
days of infection. At this time the animals injected 
with daunomycin treated vir~ suspension were all 
alive. Adriamycin also has a very beneficial effect, 
whereas dihydro daunomycin shows a moderate ac- 
tivity. The derivatives substituted in the amino sugar 
moiety are ineffective. The oncogenesis in chicken 
by RSV is also inhibited by daunomycin and its anal- 
ogues. Thus, the mean survival time is prolonged 
from 12.3 days to 28.3 days by adriamycin. Dauno- 
mycin is even more effective, whereas the other de- 
rivatives have no significant effect. 
Table 1 
Effect of daunomycin and its derivatives on the viral oncogenesis in 
mice and chicken. 
Antibiotic used Oncogenesis in mice 
by FLV 
No. of animals survived* 
No. of animals infected 
Oncogenesis in Chicken 
by RSV** 
Mean survival time 
(days) 
_ 
None 
Daunomycin 
Adriamycin 
Dihydro daunomycin 
N-guanidine-daunomycin 
N-acetyl daunomycin 
l/6 12.3 
616 30*** 
516 28.3 
316 14.2 
l/6 13.6 
O/6 12.0 
* 13 days after infection; for details see text. 
**Each experimental group contained 6 chickens. The tumor suspension (1: 10) was incubated with 50 pg/ml of the antibiotic 
at 37” for 1 hr. Control suspension was incubated without the antibiotic. 0.1. ml of this suspension was injected intraperito- 
neally. 
***One animal was still alive at the time of writing this paper. 
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Table 2 
Inhibition of reverse-transcriptasee activity of RNA tumor viruses by daunomycin derivatives. 
System Antibiotic used* 
sH-TMP incorporation into DNA 
(cpm/reaction mixt.) 
MSV(Moloney) FLV RSV 
Without virions 
Virions + RNase* * 
Complete 
- 
_ 
None 
Daunomycin 
Adriamycin 
Dihydro daunomycin 
N-guanidine daunomycin 
N-acetyl daunomycin 
7 (3.4) 7 (3.7) 7 (2.9) 
26 (13) 25 (13.4) 40 (16.8) 
202 (100) 187 (100) 237 (100) 
65 (32.1) 68 (36.3) 80 (33.7) 
66 (33.1) 83 (44.4) 86 (36.3) 
86 (42.5) 87 (46.5) 113 (47.7) 
106 (52.4) 97 (51.8) 117 (49.3) 
196 (97) 192 (102.6) 136 (57.3) 
*Antibiotic concentration = 10 pg/reaction mixt. (0.25 ml). 
**Virions containing Nonidet P-40 were preincubated at room temp for 25 min with 50 Mug/ml pf pancreatic RNase. Figures in 
parentheses are the percent of control. The reaciton conditions are described under Materials and methods. 
The inhibitory activity of daunomycin and its 
structural analogues in viral oncogenesis uggests that 
the virus-associated enzymatic activities are sensitive 
to these antibiotics. The RNA-dependent DNA poly- 
merase of virions is responsible for the synthesis of 
DNA chains on the RNA template, giving rise to a 
hybrid molecule (RNA-DNA). These DNA chains 
are released from the RNA template as single strand- 
ed DNA molecules and serve as templates for the 
synthesis of double stranded DNA. These synthetic 
processes could be affected by the daunomycin de- 
rivatives. The inhibition of reverse transcriptase ac- 
tivity of MSV-M, FLV and RSV by various dauno- 
mycin derivatives is shown in table 2. Daunomycin 
Table 3 
Inhibition of DNA-polymerase activity of FL-virions by daunomycin and its derivatives in the 
presence of various templates. 
Antibiotic used* 3H-TMP incorporation ‘H-dCMP incorporation ‘H-TMP incorporation 
into DNA into DNA into DNA 
poly (dA-dT) poly (dI.dC) ~01~ rA.(dT),, 
(cpm/reaction mixt.) (cpm/reaction mixt) (cpm/reaction mixt.) 
None 1223 (100) 1006 (100) 723 (100) 
Daunomycin 127 (10.3) 1057 (105) 159 (22) 
Adriamycin 106 (8.7) 1127 (112) 231 (31.9) 
Dihydro daunomycin 151 (12.3) 1654 (164.2) 327 (45.2) 
N-guanidine daunomycin 322 (26.3) 941 (93.5) 457 (63.2) 
N-acetyl daunomycin 1412 (115.6) 587 (58.3) 673 (93) 
*Antibiotic concentration = 5 pg/reaction mixt. (0.25 ml). The figures in parentheses indicate the percent of control. The reaction 
conditions are described under Materials and methods. 
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Table 4 
Inhibition of DNA-polymerase activity of MSV(M) by daunomycin and its derivatives in the 
presence of various templates. 
April 1972 
Antibiotic used* 3H-TMP incorporation ‘H-dGMP incorporation 
into DNA into DNA 
poly (dA-dT) poly (dI.dC) 
(cpm/reaction mixt.) (cpm/reaction mixt.) 
‘H-TMP incorporation 
into DNA 
POIY rA.(dT),, 
(cpm/reaction mixt.) 
None 5446 (100) 3757 (100) 1196 (100) 
Daunomycin 126 (2.3) 4123 (109) 467 (39) 
Adriamycin 106 (1.9) 4252 (113) 472 (39.4) 
Dihydro daunomycin 162 (3) 6446 (171.5) 552 (46.1) 
N-guanidine daunomycin 781 (14.3) 4897 (130.3) 572 (47.8) 
N-acetyl daunomycin 5607 (102.9) 4086 (108.7) 1160 (97.0) 
____- 
*Antibiotic concentration = 5 pg/reaction mixt. (0.25 ml). The figures in parentheses indicate the percent of control. The reac- 
tion conditions are described under Materials and methods. 
and adriamycin inhibit the reverse-transcriptase r ac- 
tion to 60-70% at 10 /.&reaction mixture (0.25 ml). 
The dihydro derivative is also quite effective whereas 
the N-guanidine derivative has a moderate activity. 
However, the N-acetyl derivative is completely inef- 
fective in MSV-M and FLV systems. The RSV system 
was moderately inhibited by the N-acetyl derivative. 
Synthetic polymers containing either deoxyribonu- 
cleotide or ribonucleotide strands are known to stim- 
ulate the in vitro DNA synthesis by RNA tumor vi- 
ruses [ 10,l l] . Some inhibitors of the DNA-polymerase 
reaction in RNA tumor viruses are known to exhibit 
a template-primer specificity [ 12 - 141. Table 3 
shows the inhibition of template-dependent DNA- 
polymerase activity of FLV by various daunomycin 
derivatives. 
The reactions catalyzed by poly (dA-dT) and 
poly rA.(dT)lz are highly sensitive to the action of 
daunomycin and its derivatives. Even under these 
conditions daunomycin and adriamycin are most ef- 
fective, and the N-acetyl derivative is completely in- 
active. It is interesting to note that poly (dA-dT) 
and poly rA.(dT)I,-dependent reactions are more 
sensitive to antibiotics than the endogenous reaction 
(see table 2). The DNA-polymerase reaction catalyzed 
by poly (dI.dC) is completely insensitive to these 
antibiotics. As a matter of fact, the most active deriv- 
atives (daunomycin, adriamycin and dihydrodauno- 
mycin) exhibit a slight stimulation of 3H-dGMP incor- 
poration catalyzed by poly (dI.dC). This stimulation 
is particularly noticeable in the case of dihydro 
daunomycin. Surprisingly, the N-ace@ derivative 
was found to inhibit this reaction. The mechanism 
of this inhibition is not understood. 
Table 4 shows the inhibition of template-depen- 
dent DNA-polymerase activity of MSV-M by various 
daunomycin derivatives. Compared to FLV-system 
the poly (dA-dT)-dependent reaction in this case 
is extremely sensitive to daunomycin derivatives. The 
poly rA.(dTJ 2 -dependent reaction shows a similar 
sensitivity towards the daunomycin derivatives as 
observed in the FLV system. In both these cases the 
N-acetyl derivative is completely ineffective. Very 
similar to FLV system we find here that the poly 
(dI.dC) catalyzed incorporation of 3H-dCMP is not 
inhibited by any of the derivatives. Contrary to the 
FLV system the N-acetyl derivative in this system 
did not inhibit the 3H-dGMP incorporation into DNA. 
Dihydro derivative exhibits here also a very high 
stimulatory activity. 
The present results show that the inhibition exert- 
ed by daunomycin derivatives against DNA polymerases 
from RNA tumor viruses is selectively dependent on 
the type of primer-template used in the assay system. 
The inhibitor activity of daunomycin requires specific 
structural parameters. Thus substitutions in the amino 
sugar moiety, especially N-acetylation, inhibit its anti- 
tumor activity and influence its inhibitory action on 
the DNA polymerases of RNA tumor viruses. 
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